NetworkNewsBreaks

WednesdayJul 30, 2025 9:20 am

NetworkNewsBreaks – AI Maverick Intel, Inc. (OTCID: BINP) Engages IBN to Lead Corporate Communications Strategy

AI Maverick Intel (OTC PINK: BINP), a technology-forward company focused on transforming business customer acquisition through artificial intelligence, selected IBN to manage its corporate communications efforts. AI Maverick Intel’s proprietary platform delivers human-like, AI-powered prospecting with adaptive engagement across sectors including healthcare, biotech, insurance and transportation. Following its May 2025 rebrand and platform acquisition, the company launched an enhanced version in July designed to handle transactional and consultative sales engagements with context-aware messaging and autonomous dialogues. The platform aims to shorten deal cycles and reduce acquisition costs while positioning AI Maverick to capture growth in the AI-in-marketing sector. IBN will…

Continue Reading

WednesdayJul 30, 2025 9:10 am

NetworkNewsBreaks – BluSky AI Inc. (OTC: BSAI) Signs LOI to Acquire 15 Acres in Arizona for Modular AI Expansion

BluSky AI (OTC: BSAI), a leading innovator in modular AI infrastructure, signed a Letter of Intent (LOI) to purchase approximately 15 acres of industrial land in Camp Verde, Arizona. The site includes existing electrical infrastructure capable of supporting 1.75 megawatts (MW), with plans to expand to 3.75 MW to meet growing demand. CEO Trent D’Ambrosio said the acquisition reflects BluSky AI’s mission to deliver scalable, energy-efficient compute solutions across the Southwest, positioning its SkyMod technology closer to the edge. The transaction is expected to close later this year with groundbreaking planned for mid-2026. To view the full press release, visit…

Continue Reading

WednesdayJul 30, 2025 9:00 am

NetworkNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Schedules Aug. 13 Call to Discuss Q2 Results and Provide Business Updates

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care with personalized insights, will hold a conference call Aug. 13, 2025, at 4:30 p.m. Eastern to discuss second-quarter results for the period ended June 30, 2025. The company will also provide updates on regulatory initiatives, commercial-readiness activities and anticipated milestones. CEO Robert Eno and CFO Timothy Cruickshank will host the call, followed by a question-and-answer session. To view the full press release, visit https://nnw.fm/0KtNc About HeartBeam Inc. HeartBeam is a medical technology company dedicated to transforming cardiac care by providing powerful cardiac insights wherever the patient is. The…

Continue Reading

TuesdayJul 29, 2025 12:58 pm

NetworkNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Publishes Peer-Reviewed Data Supporting PC111 as Potential Disease Modifier 

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company developing inflammation and immunology biological products and providing boutique CDMO services, announced the publication of a peer-reviewed article in the Journal of Dermatological Treatment confirming the disease-modifying potential of PC111, a first-in-class human anti-Fas Ligand monoclonal antibody. The study demonstrated PC111’s ability to prevent blister formation in humanized models of pemphigus by targeting soluble Fas Ligand, offering a differentiated, non-immunosuppressive approach. Data also highlighted potential use in SJS/TEN, a life-threatening dermatological condition. CEO Amir Reichman said the findings reinforce PC111’s potential to transform treatment for these high unmet-need indications and deliver meaningful value…

Continue Reading

TuesdayJul 29, 2025 12:50 pm

NetworkNewsBreaks – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) Highlights IzoView Breast CT Advantages Over Existing Imaging Technologies

Izotropic (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3), a medical device company developing imaging-based products for breast cancer detection and treatment, released an educational overview comparing its IzoView Breast CT Imaging System to current breast imaging technologies. IzoView offers true 3D, ultra-high-resolution imaging without breast compression and is designed to bridge the gap between digital breast tomosynthesis and MRI. Developed under a global license from UC Davis, IzoView delivers 100x greater spatial resolution than MRI at a lower cost and with shorter scan times, aiming to improve screening, diagnosis, and treatment planning, particularly in women with dense breast tissue. To view…

Continue Reading

TuesdayJul 29, 2025 12:13 pm

NetworkNewsBreaks – Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF) Spotlighted by Bloomberg for Upcoming Launch of Louisiana Rare Earths Plant

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) has been featured in a Bloomberg article for its role in helping reshape North America’s critical minerals infrastructure with its landmark facility in Louisiana set to begin production in May 2026. Backed by $18.4 million in U.S. Department of Defense funding and located within a designated foreign-trade zone, the $80 million rare earths plant will handle materials used in defense, electric vehicles, and consumer electronics. CEO Pat Ryan described the site as a strategic hub that enables global feedstock inputs and tariff-free exports to partners in Japan and beyond. The article also…

Continue Reading

TuesdayJul 29, 2025 11:54 am

NetworkNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) CEO to Join Fireside Chat at BTIG Virtual Biotechnology Conference

NRx Pharmaceuticals (NASDAQ: NRXP), announced that CEO and Chairman Prof. Jonathan Javitt, MD, MPH will participate in a fireside chat at the BTIG Virtual Biotechnology Conference on July 29–30, 2025. The discussion, scheduled for 8:00 a.m. EDT on July 30, will feature Prof. Samuel Wilkinson, MD, of Yale School of Medicine, and BTIG Research Analyst Dr. Thomas Shrader. The session will focus on neuroplasticity in treating CNS disorders, including the use of ketamine and other neuroplastic and psychedelic drugs for depression, suicidality, and PTSD. To view the full press release, visit https://nnw.fm/Kdcs0 About NRx Pharmaceuticals, Inc. NRx Pharmaceuticals is a…

Continue Reading

TuesdayJul 29, 2025 11:40 am

NetworkNewsBreaks – BluSky AI Inc. (OTC: BSAI) to Acquire Land and 50MW Power Access for Delta Data Center Development

BluSky AI (OTC: BSAI), a modular AI infrastructure innovator, announced it has signed a non-binding letter of intent with Creekstone Energy LLC to acquire 25 acres within the Delta Data Center Development, including access to up to 50 megawatts of scalable power. The site, located within Creekstone’s Delta Gigasite in Utah, will serve as a foundation for BluSky’s next-generation SkyMod compute campuses designed to deliver secure, efficient, and sustainable AI infrastructure. CEO Trent D’Ambrosio said the project underscores BluSky’s commitment to building future-ready modular AI facilities, with groundbreaking anticipated in late 2026. To view the full press release, visit https://nnw.fm/dEMHw…

Continue Reading

TuesdayJul 29, 2025 11:28 am

NetworkNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Expands Commercialization of AI Agents Built on IBM (NYSE: IBM) watsonx.ai 

Datavault AI (NASDAQ: DVLT), a leader in AI data experience, valuation, and monetization, announced the expanded commercialization of its flagship AI agents, DataScore(R) and DataValue(R), built on IBM (NYSE: IBM) watsonx.ai. IBM will provide multi-year AI engineering talent and technical expertise to accelerate Datavault’s enterprise-scale offerings across finance, healthcare, sports, entertainment, and government. As a Platinum IBM Partner, Datavault will collaborate with IBM’s sales force and partner network to drive AI adoption and data monetization. CEO Nathaniel Bradley called the collaboration a key milestone in Datavault’s global commercialization roadmap. To view the full press release, visit https://nnw.fm/OpONl About Datavault AI…

Continue Reading

TuesdayJul 29, 2025 10:40 am

NetworkNewsBreaks – Bollinger Innovations, Inc. (NASDAQ: BINI) Eliminates Warrants and $25.3 Million in Convertible Notes to Strengthen Balance Sheet 

Bollinger Innovations (NASDAQ: BINI), an emerging electric vehicle manufacturer, announced it has eliminated all warrants and $25.3 million of convertible notes through agreements with existing noteholders to exchange the debt into newly created preferred stock. CEO and Chairman David Michery said the move improves the company’s capital structure and reflects continued investor support. Bollinger’s commercial EV lineup includes the ONE Class 1 cargo van, THREE Class 3 cab chassis, and the B4 Class 4 chassis cab, all compliant with U.S. Federal Motor Vehicle Safety Standards, EPA, and CARB certifications. To view the full press release, visit https://nnw.fm/e92hs About Bollinger Innovations,…

Continue Reading